HUP9601791A3 - Cyclodextrin derivatives, process for producing them, and their use for introducing hydrophob molekules into structured capillaractive systems - Google Patents

Cyclodextrin derivatives, process for producing them, and their use for introducing hydrophob molekules into structured capillaractive systems

Info

Publication number
HUP9601791A3
HUP9601791A3 HU9601791A HUP9601791A HUP9601791A3 HU P9601791 A3 HUP9601791 A3 HU P9601791A3 HU 9601791 A HU9601791 A HU 9601791A HU P9601791 A HUP9601791 A HU P9601791A HU P9601791 A3 HUP9601791 A3 HU P9601791A3
Authority
HU
Hungary
Prior art keywords
molekules
capillaractive
hydrophob
structured
introducing
Prior art date
Application number
HU9601791A
Other languages
English (en)
Original Assignee
Commissariat Energie Atomique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique filed Critical Commissariat Energie Atomique
Publication of HUP9601791A2 publication Critical patent/HUP9601791A2/hu
Publication of HU9601791D0 publication Critical patent/HU9601791D0/hu
Publication of HUP9601791A3 publication Critical patent/HUP9601791A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
HU9601791A 1995-06-29 1996-06-28 Cyclodextrin derivatives, process for producing them, and their use for introducing hydrophob molekules into structured capillaractive systems HUP9601791A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9507841A FR2736056B1 (fr) 1995-06-29 1995-06-29 Derives de cyclodextrines, leur preparation et leur utilisation pour incorporer des molecules hydrophobes dans des systemes de tensioactifs organises

Publications (3)

Publication Number Publication Date
HUP9601791A2 HUP9601791A2 (en) 1997-05-28
HU9601791D0 HU9601791D0 (en) 1997-06-30
HUP9601791A3 true HUP9601791A3 (en) 1997-08-28

Family

ID=9480518

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9601791A HUP9601791A3 (en) 1995-06-29 1996-06-28 Cyclodextrin derivatives, process for producing them, and their use for introducing hydrophob molekules into structured capillaractive systems

Country Status (8)

Country Link
US (1) US5821349A (hu)
EP (1) EP0751150B1 (hu)
JP (1) JPH0912605A (hu)
AU (1) AU699482B2 (hu)
DE (1) DE69621521T2 (hu)
FR (1) FR2736056B1 (hu)
HU (1) HUP9601791A3 (hu)
ZA (1) ZA965364B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792942B1 (fr) * 1999-04-29 2001-06-08 Commissariat Energie Atomique Cyclodextrines amphiphiles, leur preparation et leur utilisation pour solubiliser des systemes organises et incorporer des molecules hydrophobes
WO2001070697A1 (en) * 2000-03-20 2001-09-27 Teva Pharmaceutical Industries Ltd. Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and n-(4-methoxyphenyl)-3-chloropropionamide
BR0110679A (pt) * 2000-04-28 2004-04-20 Univ Dublin Derivados anfìfilos macrocìclicos e seus análogos
US6527887B1 (en) 2002-01-18 2003-03-04 Mach I, Inc. Polymeric cyclodextrin nitrate esters
FR2861396B1 (fr) 2003-10-24 2005-12-16 Commissariat Energie Atomique Derives amphiphiles de cyclodextrines,leur procede de preparation et leurs utilisations
WO2006001844A2 (en) * 2004-01-29 2006-01-05 Pinnacle Pharmaceuticals β-CYCLODEXTRIN DERIVATIVES AND THEIR USE AGAINST ANTHRAX LETHAL TOXIN
AU2006211173A1 (en) * 2005-01-28 2006-08-10 Pinnacle Pharmaceuticals, Inc. Beta-cyclodextrin derivatives as antibacterial agents
JP5364923B2 (ja) * 2009-01-28 2013-12-11 学校法人福岡大学 多機能性シクロデキストリン誘導体、その包接化合物およびそれらの製造方法。
US20120058178A1 (en) 2009-03-30 2012-03-08 Eisai R&D Management Co., Ltd. Liposome Composition
US9968583B2 (en) 2009-03-30 2018-05-15 Eisai R & D Management Co., Ltd. Method of manufacture of liposome composition
US11083705B2 (en) 2019-07-26 2021-08-10 Eisai R&D Management Co., Ltd. Pharmaceutical composition for treating tumor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
WO1995015746A1 (en) * 1993-12-10 1995-06-15 The School Of Pharmacy Liposome delivery systems

Also Published As

Publication number Publication date
JPH0912605A (ja) 1997-01-14
AU699482B2 (en) 1998-12-03
HU9601791D0 (en) 1997-06-30
EP0751150A1 (fr) 1997-01-02
AU5616496A (en) 1997-01-09
DE69621521D1 (de) 2002-07-11
HUP9601791A2 (en) 1997-05-28
US5821349A (en) 1998-10-13
FR2736056B1 (fr) 1997-08-08
ZA965364B (en) 1997-01-23
DE69621521T2 (de) 2003-01-02
EP0751150B1 (fr) 2002-06-05
FR2736056A1 (fr) 1997-01-03

Similar Documents

Publication Publication Date Title
HUP9600647A1 (en) Phosphono-monoester-nucleinic acids, process for producing them, and their use
HUP9801688A3 (en) Acetamide derivatives, process for producing the same, and medicinal composition containing the same
HUP9602685A3 (en) Substituted quinoline-2-carboxylic-amides, process for producing them, their use as medicines and intermediates
AU7489596A (en) Reinforced formed part, process for its production and its use
HUP9802300A3 (en) N-heteroaryl-pyridinesulfonamide derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9601492A3 (en) Benzimidazol derivatives, process for producing them and pharmaceutical use of them
HUP0000449A3 (en) N-subsituted dioxothiazolidylbenzamide derivatives and process for producing the same
HUP9801697A3 (en) Modified mp52-protein and process for producing thereof
IL123767A (en) Process for producing fruit-product and product produced thereby
HUP9603433A2 (en) 4-6-diaryl-pyrimidine-derivatives, process for producing them and pharmaceutical compositions containing them
HUP9600071A3 (en) Indolo-piperidine derivatives, pharmaceutical compositions containing them, process for producing them and their use
HUP9601954A1 (en) Process for producing creatine and creatine-mono-hydrate
HUP9602681A1 (en) Hydroxy-pyridinone derivatives, process for producing them and pharmaceutical compositions containing them
HUP9600876A3 (en) Benzonitril- and -fluoride derivatives, pharmaceutical compositions containing them, process for producing them and their use
HU9600624D0 (en) Piperidine derivatives, process for producing them and their pharmaceutical use
HUP9801766A3 (en) 6-carboxamido dihydropyran derivatives, process for producing them and medicaments containing the same
GR3029933T3 (en) Process for producing n-arylhydroxylamines and n-hetarylhydroxylamines
HUP9601791A3 (en) Cyclodextrin derivatives, process for producing them, and their use for introducing hydrophob molekules into structured capillaractive systems
ZA966601B (en) Process for producing erythromycin derivatives.
HUP9900105A3 (en) Momopiperazine derivatives, process for producing them and pharmaceutical compositions containing them
HUP9903696A3 (en) 5-naphthalen-1-yl-1,3-dioxane derivatives, medicaments containing the same and process for producing them
HUP9600213A2 (en) 4-mercapto-benzoyl-guanidine derivatives, process for producing them and pharmaceutical compositions containing them
EP0787850A4 (en) MODIFIED FIBERS METHOD FOR PRODUCING THE SAME AND PRODUCT BASED ON THIS FIBER
HU9602080D0 (en) 12,13-epoxi-tylosin derivatives and process for producing them
HUT66161A (en) 2-chloro-4-methyl-5-halogenoalkyl-1,3-thiasole derivatives and process for producing them